Cargando…

Evaluation of three different laboratory methods to detect preformed human leukocyte antigen antibodies in a South African kidney transplant population

BACKGROUND: Anti-human leukocyte antigen antibodies (anti-HLA) play a crucial role in graft. Detection of anti-HLA, both pre- and post-transplant is a crucial investigation in clinical organ transplantation. OBJECTIVES: Three methodologies for the detection of lymphocytotoxic antibodies were compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwofie, Luyanda, Anderson, Ronald, Steel, Helen, Meyer WA, Pieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Makerere Medical School 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568216/ https://www.ncbi.nlm.nih.gov/pubmed/34795730 http://dx.doi.org/10.4314/ahs.v21i2.32

Ejemplares similares

Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies
por: Del Bello, Arnaud, et al.
Publicado: (2020)

Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients
por: Kgokolo, Mahlatse C. M., et al.
Publicado: (2022)

Influence of Preformed Antibodies in Liver Transplantation
por: Legaz, Isabel, et al.
Publicado: (2020)

Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma
por: Malinga, Nonkululeko Z., et al.
Publicado: (2022)

Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3
por: Rapoport, Bernardo L., et al.
Publicado: (2023)

Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome
por: Molina, Juan, et al.
Publicado: (2017)

Pro-Inflammatory Interactions of Dolutegravir with Human Neutrophils in an In Vitro Study
por: Theron, Annette J., et al.
Publicado: (2022)

Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules
por: Rapoport, Bernardo L., et al.
Publicado: (2022)

Human leukocyte antigen antibody incompatible renal transplantation
por: Krishnan, N. S., et al.
Publicado: (2012)

Living Donor Liver Transplantation in Patients with Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies Using Preoperative Desensitization Therapy According to Intensity of Donor-Specific Antibodies: A Single-Center Study
por: Ogawa, Kohei, et al.
Publicado: (2023)

Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV-Infected Participants
por: Steel, Helen C., et al.
Publicado: (2018)

Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms
por: Barreiro, Olga, et al.
Publicado: (2008)

Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation
por: Muro, Manuel, et al.
Publicado: (2023)

Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes
por: Gniewkiewicz, Michal, et al.
Publicado: (2023)

Renal transplant patients with preformed anti-HLA antibodies: early biopsy findings and clinical outcomes
por: de Sousa, Marcos Vinicius, et al.
Publicado: (2019)

The impact of preformed donor‐specific antibodies in living donor liver transplantation according to graft volume
por: Goto, Ryoichi, et al.
Publicado: (2022)

What Lies beneath: Preformed Autoantibodies and Lung Transplantation
por: Duncan, Steven R., et al.
Publicado: (2019)

Immunological risk assessment and human leukocyte antigen antibody testing in kidney transplantation
por: Phanish, M. K.
Publicado: (2016)

Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation
por: Zhang, Xiaohai, et al.
Publicado: (2017)

Availability and use of assistive technologies at selected South African public libraries
por: Mamafha, Takalani M.M., et al.
Publicado: (2023)

Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report
por: Thammanichanond, Duangtawan, et al.
Publicado: (2022)

Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients
por: Meyer, Pieter, et al.
Publicado: (2018)

Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients
por: de Sousa, Marcos Vinicius, et al.
Publicado: (2018)

Simplified Preformed Silo Bag Crafted from Standard Equipment in African Hospitals
por: Elhosny, Ayman, et al.
Publicado: (2021)

Human Leukocyte Antigen Diversity: A Southern African Perspective
por: Tshabalala, Mqondisi, et al.
Publicado: (2015)

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
por: Uffing, Audrey, et al.
Publicado: (2019)

Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey
por: Akamatsu, Nobuhisa, et al.
Publicado: (2021)

Clinical relevance of donor-specific human leukocyte antigen antibodies after pediatric liver transplantation
por: Liu, Wei, et al.
Publicado: (2021)

Patients on the Transplant Waiting List Have Anti-Swine Leukocyte Antigen Class I Antibodies
por: Wang, Zheng-Yu, et al.
Publicado: (2023)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
por: Glotz, Denis, et al.
Publicado: (2019)

Pharmacological control of neutrophil-mediated inflammation: Strategies targeting calcium handling by activated polymorphonuclear leukocytes
por: Tintinger, Gregory R, et al.
Publicado: (2009)

South African consumers’ perceptions of front-of-package warning labels on unhealthy foods and drinks
por: Bopape, Makoma, et al.
Publicado: (2021)

Preparation of Preformed Iodixanol Gradients
por: Graham, John
Publicado: (2002)

Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide
por: Kanakry, Christopher G., et al.
Publicado: (2017)

Significance of Semiquantitative Assessment of Preformed Donor-Specific Antibody Using Luminex Single Bead Assay in Living Related Liver Transplantation
por: Yoshizawa, Atsushi, et al.
Publicado: (2013)

Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody
por: Egashira, Shuhei, et al.
Publicado: (2023)

HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients
por: Meyer, Pieter WA, et al.
Publicado: (2011)

It Is Time to Consider Human Leukocyte Antigen Compatibility in Lung Transplantation
por: Rhee, Chin Kook
Publicado: (2022)

Development of Human Leukocyte Antigen (HLA) Antibodies Against Vascular Homograft Donor in Pediatric Heart Transplant Recipients
por: Jahnukainen, Timo, et al.
Publicado: (2019)

Human leukocyte antigen class I (A, B and C) allele and haplotype variation in a South African Mixed ancestry population
por: Loubser, Shayne, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cor3nt696leha3dvl69fgu8cao